LexinFintech Holdings Ltd. (LX) Financial Statements
LexinFintech Holdings Ltd. (LX) reported trailing twelve-month revenue of $13.2B (down 7.4% year on year) and net income of $1.7B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · read by EquiReason
LXLexinFintech Holdings Ltd.Follow LX — free
—
Price chart with a free account
- Market cap
- 107.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 23 Nov, in 30 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters.
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.58 | 7.60 | 10.60 | 11.65 | 11.38 | 9.87 | 13.06 | 14.20 | 13.15 | — | |
| Gross profit | 1.32 | 3.01 | 4.99 | 3.63 | 5.75 | 3.03 | 4.51 | 5.03 | 4.47 | — | |
| Research & development | 0.24 | 0.32 | 0.42 | 0.47 | 0.55 | 0.58 | 0.51 | 0.58 | 0.60 | — | |
| Pre-tax income | 0.47 | 2.11 | 2.71 | 0.69 | 2.77 | 1.03 | 1.33 | 1.35 | 2.08 | — | |
| Income tax | 0.23 | 0.13 | 0.41 | 0.09 | 0.44 | 0.20 | 0.26 | 0.25 | 0.40 | — | |
| Net income | 0.24 | 1.98 | 2.29 | 0.59 | 2.33 | 0.83 | 1.07 | 1.10 | 1.68 | — | |
| Diluted EPS ($) | — | — | — | — | — | 2.21 | 3.17 | 3.24 | 4.72 | — | |
| Diluted shares (bn) | 0.141 | 0.363 | 0.376 | 0.411 | 0.415 | 0.393 | 0.360 | 0.339 | 0.355 | — |
USD billions · SEC XBRL
LexinFintech Holdings Ltd. — questions
- What is LexinFintech Holdings Ltd.'s revenue?
- $13.2B over the twelve months to the latest filing, down 7.4% year on year, from its 10-Q and 10-K filings.
- What is LexinFintech Holdings Ltd.'s net income?
- $1.7B over the twelve months to .
Every figure on this page comes from LexinFintech Holdings Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.